Viewing Study NCT00449917



Ignite Creation Date: 2024-05-05 @ 5:23 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00449917
Status: COMPLETED
Last Update Posted: 2011-10-06
First Post: 2007-03-20

Brief Title: Visiobiane Anti-age Effects on Vision Parameters
Sponsor: PiLeJe
Organization: PiLeJe

Study Overview

Official Title: Study of the Effects of Visiobiane Anti-age Dietary Supplement on Macular Pigment Optical Density Contrast Sensibility and Visual Acuity
Status: COMPLETED
Status Verified Date: 2011-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine the benefits of Visiobiane Anti-age dietary supplement on macular pigment optical density contrast sensibility and visual acuity Additionally the study would like to evaluate seric variations of carotenoids and the total antioxydant capacity
Detailed Description: Visiobiane study is a randomized trial of 30 participants designed to assess the effects of oral supplementation of macular xanthophylls lutein and zeaxanthin and omega-3 LCPUFAs for the eyes protection The study will enroll healthy participants aged 45 to 55 years 15 subjects will be assigned in placebo group and 15 in experimetal group Visiobiane anti-age They will be supplemented for 24 weeks

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None